LHC Group Inc
F:LH6
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.877
0.9208
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| US |
L
|
LHC Group Inc
F:LH6
|
27.9m EUR |
Loading...
|
|
| US |
|
CVS Health Corp
NYSE:CVS
|
90.2B USD |
Loading...
|
|
| US |
C
|
Cigna Group
XMUN:CGN
|
63B EUR |
Loading...
|
|
| US |
|
Cigna Corp
NYSE:CI
|
72.3B USD |
Loading...
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
27.9B EUR |
Loading...
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
21.8B EUR |
Loading...
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.3B USD |
Loading...
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
20.4B USD |
Loading...
|
|
| US |
|
Guardant Health Inc
NASDAQ:GH
|
14.3B USD |
Loading...
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR |
Loading...
|
|
| AU |
|
Sonic Healthcare Ltd
ASX:SHL
|
11.1B AUD |
Loading...
|
Market Distribution
| Min | -4 087 900% |
| 30th Percentile | -5.1% |
| Median | 6% |
| 70th Percentile | 14.8% |
| Max | 1 032 600% |
Other Profitability Ratios
LHC Group Inc
Glance View
In the heart of Lafayette, Louisiana, LHC Group Inc. carved a niche in the labyrinthine healthcare sector with a singular focus: providing quality home health care. Founded in 1994, the company matured into one of the nation's preeminent providers of home health and hospice services. The company's operations are multifaceted, encompassing home health, hospice, and long-term acute care services, as well as healthcare innovations through partnerships with hospitals. With a patient-first mantra, LHC Group captures the essence of healthcare evolution by delivering personalized care directly to the doorsteps of those in need. Their comprehensive offerings include skilled nursing, physical therapy, and in-home aide services, sustained by a decentralized structure that ensures each local agency operates with an adept understanding of community-specific needs. Revenue streams flow primarily from Medicare and Medicaid reimbursements, alongside private insurance and out-of-pocket payments, creating a diverse financial portfolio. The fragmented nature of the home healthcare sector presents LHC Group with unique growth opportunities through acquisitions and strategic partnerships. By aligning with hospitals and health systems, LHC Group not only expands its service reach but also enhances efficiencies in patient care transitions. This synergy not only boosts patient satisfaction through reduced hospital readmissions but also strengthens the company’s financial resilience. The ability to navigate regulatory landscapes and adapt to shifting demographics underscores LHC Group’s role as a key player in shaping the future of home healthcare in America.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for LHC Group Inc is 34.2%, which is above its 3-year median of 29.5%.
Over the last 7 months, LHC Group Inc’s Operating Margin has increased from 24.9% to 34.2%. During this period, it reached a low of 24.9% on Dec 1, 2024 and a high of 34.1% on Jul 30, 2025.